Scinovex
reviewTop 1% cited

Nuclear transcription factor-κB as a target for cancer drug development

Leukemia · 2002 · Vol. 16(6) · pp. 1053–1068
Amit GargBB Aggarwal
NF-κB Signaling PathwaysCytokine Signaling Pathways and InteractionsNatural product bioactivities and synthesisTranscription factorCancerNFKB1NF-κBBiologyInflammationCancer researchDrug developmentDrugDrug discovery

MeSH terms

Antineoplastic AgentsHumansModels, BiologicalNeoplasmsNF-kappa BDrug Delivery SystemsGene Deletion
Citations
438
FWCI
13.80
field-weighted impact
References
287
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.